Cancer Clinician and Translational Scientist Dr. Daniela Matei will become the next director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center following a national search, Houston Methodist ...

Scientists discover that sickle cell disease forces the brain to recruit extra "attention backup" to maintain normal cognitive function.

Good morning, ladies and gentlemen, and welcome to the ADC Therapeutics Q4 2025 Earnings Conference Call. [Operator Instructions] I will now turn the call over to Nicole Riley, Head of Investor ...

Earnings call ADCT’s Q4 2025 saw ZYNLONTA net product revenue rise to $22.3M (up from $16.4M YoY), with full-year sales at $73.6M, broadly stable versus 2024. Operating expenses were cut by 15% in Q4, ...

Fred Hutch Cancer Center hematologists took center stage at the 2026 Tandem Meetings, a multidisciplinary meeting of experts in the field of blood stem cell transplantation, held in Salt Lake City ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced positive data from a pre-specified Week 36 interim ...

Today, hematology analyzers can collect vast amounts of data about cell characteristics, that subsequently improve disease detection. Advanced systems can perform a complete blood count (CBC) and ...

Received FDA clearance of Investigational New Drug application (IND) for PRT12396, mutant-selective JAK2V617F inhibitor in the first quarter of ...

CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $555 million and $1.9 billion for the fourth quarter and full ...

CARVYKTI- (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $555 million and $1.9 billion for the fourth quarter and full year 2025, respectivelySurpassed milestone of more than ...

Domain adaptation may be a novel creative solution to predict infection risk in patients with chronic lymphocytic leukemia ...